Johnson & Johnson (SNSE:JNJ)

Market Cap	462.60T
Revenue (ttm)	88.44T
Net Income (ttm)	24.11T
Shares Out	n/a
EPS (ttm)	9,930.89
PE Ratio	19.19
Forward PE	18.45
Dividend	4,865.72 (2,546.83%)
Ex-Dividend Date	Nov 25, 2025

Volume	n/a
Average Volume	n/a
Open	n/a
Previous Close	191.05
Day's Range	n/a
52-Week Range	143.62 - 191.05
Beta	0.66
RSI	100.00
Earnings Date	Jan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Santiago Stock Exchange
• Ticker Symbol: JNJ

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD